NCT05446220Completed
Twelve-year Follow-up on the Treatment of Obese Pregnant Women (TOP) Study
Source: ClinicalTrials.gov · Last updated 21 Nov 2025
Brief summary (registry, in English)
The participant (both mother and child) in the initial TOP study will be invited to a follow-up study to evaluate the effect of life style intervention during pregnancy on both mother and their offspring 12 years after the intervention. The study will contribute to understanding the transfer of obesity between generations and how to treat as well as prevent obesity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 497 (actual)
- First submitted
- 1 Jul 2022
- Start date
- 5 Jan 2023
- Primary completion date
- 26 Sept 2025
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Diseases
- Obesity
- NCT number
- NCT05446220
What you commit to
- Study type: Interventional
- Participants enrolled: 497
- From 5 Jan 2023 to the primary completion date, 26 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There are no exclusion criteria as the potential study population has already been selected at the baseline study in 2009-2012
Who the study is looking for
- Participants/mothers in the initial TOP study will be invited with their offspring born following the pregnancy during the initial study to the 12-year follow-up study
Age in the registry: 12 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Steno Diabetes Center Copenhagen Coordinator of this site? Confirm its status | Herlev | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.